VKTX Earnings

Quarterly EPS
$-0.22
Q3 2024
$-0.32
Q4 2024
$-0.41
Q1 2025
$-0.58
Q2 2025
$-0.81
Q3 2025
$-1.38
Q4 2025
$-1.37
Q1 2026
$-1.10
Q2 2026
Latest RevenueN/A
Latest Net Income-128022000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.100-128022000-89.7%
Q1 2026-$1.370-158325000-234.1%
Q4 2025-$1.380-157662000-331.2%
Q3 2025-$0.810-90787000-268.2%
Q2 2025-$0.580-65561000-190.0%
Q1 2025-$0.410-45629000-57.7%
Q4 2024-$0.320-35417000-28.0%
Q3 2024-$0.220-24940000+4.3%
Q2 2024-$0.200-22250000
Q1 2024-$0.260-27441000
Q4 2023-$0.250-24605000
Q3 2023-$0.230-22534000
Viking Therapeutics (VKTX) — Earnings